Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

UHFUS Characterization of Normal Lymphatic Anatomy

NCT: NCT07677839 · RECRUITING

NCT IDNCT07677839
StatusRECRUITING
Start Date2026-06-17
Completion2036-09-01
SponsorUniversity of California, Davis (OTHER)
First posted
Last updated

Brief Summary

This is a prospective pilot study of breast cancer patients undergoing axillary lymph node dissection (ALND) or sentinel lymph node biopsy (SLNB). Participants will undergo ultra-high frequency ultrasound (UHFUS) imaging with indocyanine green (ICG) dye to map lymphatic channels between the wrist and elbow to investigate normal lymphatic anatomy in patients with breast cancer.

Frequently Asked Questions

What is UHFUS Characterization of Normal Lymphatic Anatomy?

UHFUS Characterization of Normal Lymphatic Anatomy is a clinical trial registered under NCT07677839. Current status: RECRUITING.

What is the status of NCT07677839?

The current status of NCT07677839 (UHFUS Characterization of Normal Lymphatic Anatomy) is: RECRUITING.

When did UHFUS Characterization of Normal Lymphatic Anatomy start?

UHFUS Characterization of Normal Lymphatic Anatomy started on 2026-06-17.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.